We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Taylor & Francis at ISMPP Virtual Meeting, June 2020

We are pleased to offer you

FREE access to 5 articles of your choice from across all categories.

The token will expire after the 5 allowances are used up and needs to be activated by July 31, 2020.

Explore abstracts from the 2020 16th Annual and European Meetings of ISMPP.

Find out more

Taylor & Francis is delighted to be attending the 16th Annual Meeting of International Society for Medical Publication Professionals (ISMPP). Due to COVID-19, the meeting is now taking place virtually on June 16-18, 2020.

We are also excited to announce that our Medical Editor Kelly Soldavin will be part of an open discussion called " I'm a Publisher - Ask Me Anything! " on the 16th of June at 11:45am EDT. Session information is available HERE .

 

To speak to one of our conference representatives, contact Kelly Soldavin or Ross Ruriani .

Taylor & Francis' journal portfolio covers the entire research and development pipeline and includes cutting-edge articles across key therapy areas including but not limited to oncology, drug discovery, hematology and immunology. We work with all of the top 10 largest drug companies ranked by Forbes, and our range of publication options and outputs, coupled with the global reach of our platform, allows your work to reach the right audience at the right time, including medical professionals, clinical researchers, and pharma leaders.  

Like you, we value high visibility and timely publication. To extend your research impact, publish Open Access and use our Accelerated Publication service, which can fast-track your article from submission to online publication in as little as three weeks.

The following two journals provide ethical, unbiased and rapid publication of quality content that is validated by rigorous peer review. If you are interested in publishing your research in our journals, get in touch with our expert editorial team today.

A MEDLINE-indexed, peer-reviewed, international journal for the publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations. 

Find out more

Serving the international pharmacoeconomics and healthcare-research community, it publishes economic assessments of novel therapeutic and device interventions, along-side studies that measure therapeutic or preventative outcomes, and policy issues.

Find out more

Dove Medical Press

Dove Medical Press Ltd is part of Taylor & Francis Group, specializing in the publication of Open Access peer-reviewed journals across medicine and health. Explore our full portfolio of journals here.

Dovepress

Taylor & Francis: Our Medical Writing Books

Taylor & Francis publish a range of books across medical and health sciences, including a range of books that cover all aspects of medical writing such as Writing High-Quality Medical Publications: A User's Manual by Stephen W. Gutkin and Getting Research Published 3E by Elizabeth Wager.

Explore our full list of medical books today.

Find out more

All COVID-19 related, peer-reviewed research published in Taylor & Francis journals is free to access and available for anyone to read here .